REGENXBIO Inc. (FRA:RB0)

Germany · Delayed Price · Currency is EUR

6.75

-0.35 (-4.93%)

Last updated: Feb 23, 2026, 8:06 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biotechnology	83.33M	90.24M	112.72M	470.35M	154.57M
Biotechnology Growth	-7.66%	-19.94%	-76.03%	204.30%	338.70%
Total	83.33M	90.24M	112.72M	470.35M	154.57M
Total Growth	-7.66%	-19.94%	-76.03%	204.30%	338.70%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United Arab Emirates	8.33M	-	-	-	-
Germany	8.33M	-	11.27M	-	-
United States	30.00M	28.88M	39.45M	32.92M	123.65M
United States Growth	3.88%	-26.81%	19.83%	-73.37%	289.96%
Foreign	36.66M	61.36M	62.00M	65.85M	30.91M
Foreign Growth	-40.25%	-1.02%	-5.85%	113.01%	777.40%
Bermuda	-	-	-	371.57M	-
Total	83.33M	90.24M	112.72M	470.35M	154.57M
Total Growth	-7.66%	-19.94%	-76.03%	204.30%	338.70%

Source: S&P Global Market Intelligence.